NPFFR2 Contributes to the Malignancy of Hepatocellular Carcinoma Development by Activating RhoA/YAP Signaling.
Shin Y, Jung W, Kim MY, Shin D, Kim GH, Kim CH, Park SH, Cho EH, Choi DW, Han CJ, Lee KH, Kim SB, Shin HJ.
Shin Y, et al.
Cancers (Basel). 2022 Nov 27;14(23):5850. doi: 10.3390/cancers14235850.
Cancers (Basel). 2022.
PMID: 36497331
Free PMC article.
Moreover, we found that the malignant function of NPFFR2 depends on RhoA and YAP signaling. Inhibition of Rho kinase activity completely restored the phenotypes induced by NPFFR2, and RhoA/F-Actin/YAP signaling was controlled by NPFFR2. These findings demonst …
Moreover, we found that the malignant function of NPFFR2 depends on RhoA and YAP signaling. Inhibition of Rho kinase activity complet …